IL11 and colorectal carcinoma: Alternatively, Calon and colleagues described TGF-beta-activated CAFs secreting IL-6 and IL-11 leading to enhanced STAT-3-dependent survival and spreading of metastatic CRC cells (Calon et al., 2012).